Deoxycytidine protects normal bone marrow progenitors against Ara-C and gemcitabine cytotoxicity without compromising their activity against cisplatin-resistant human ovarian cancer cells

This publication has 17 references indexed in Scilit:

• Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.
  Journal of Clinical Oncology, 1991
• Expression of glutathione-related enzymes in human bladder cancer cell lines
  Biochemical Pharmacology, 1990
• Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity
  Blood, 1987
• Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion
  Biochemical Pharmacology, 1985
• Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions.
  Journal of Clinical Investigation, 1981
• A rapid and sensitive high pressure liquid chromatography assay for deoxyribonucleoside triphosphates in cell extracts
  Analytical Biochemistry, 1979
• Granuloerythropoietic colonies in human bone marrow, peripheral blood, and cord blood
  Blood, 1978
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976
• Cell-mediated immunity to human malignant cells
  American Journal of Obstetrics and Gynecology, 1972
• Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues
  Analytical Biochemistry, 1969